Service user involvement in clinical guideline development and implementation: Learning from mental health service users in the UK by Harding, E et al.
 1 
Patient and public involvement in clinical treatment guideline development and 
implementation: Learning from mental health service users in the UK. 
 
Emma Harding (1), Dora Brown (2) , Mark Hayward (3) and Catherine Johnson 
Pettinari (4). 
 
Declarations of interest: Emma Harding is a former service user representative on a 
clinical guideline development group, Catherine Pettinari was Centre Manager of the 
National Collaborating Centre for Mental Health while this study was conducted. Mark 
Hayward and Dora Brown declare no competing interests.   
 
(1) BSc (Hons), MSc, PsychD. South London and Maudsley Mental Health NHS 
Foundation Trust. 
(2) University of Surrey, Guildford, Surrey. BSc, PhD. 
(3) University of Sussex 
(4) PhD Center for Evidence-based Policy, Oregon Health and Science University. 
 
Address for correspondence: emma.harding@slam.nhs.uk, St Giles Support and 
Recovery Team 1, St Giles House, St Giles Rd, London SE5 8AZ. Tel: 0203 228 1800. 
Fax: 020 3228 1845 
 
Patient and public involvement in clinical treatment guideline development and 
implementation: Learning from mental health service users in the UK. 3599 words 
 
Abstract 
 
The participation of patients and the public in the development of clinical treatment 
guidelines is increasingly valued in international guideline programmes.  This paper 
extends the findings of Harding et al. (2010) exploration of the views of service users of 
mental health resources who participated in NICE guideline development groups 
developing UK clinical treatment guidelines for mental health related disorders.  In this 
research,   service users reported not unduly obstructed by some of the concerns raised 
about their involvement as lay members, influencing the relevance of recommendations 
to the individual consumer of the service, and grappling with the opaque nature of 
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decision-making processes and asymmetries in power. We argue that these insights, 
combined with observations from research in guideline development and advances in 
the recovery movement and in the shared decision-making clinical model leads to 
progress in the guideline development topics of translation of evidence to 
recommendations, optimising the acceptability of treatment recommendations to service 
users, participants in the treatment decision being different but equal and reconciling 
different types of knowledge.   
 
Context 
 
The past decade has seen significant progress in the contributions of patients and 
members of the public to clinical treatment guidelines.  Besides the active patient 
involvement in guideline development groups (GDGs) fostered in NICE guidelines in the 
UK, there exists today a wide variety of guideline programmes across the world, along 
with an international cooperative initiative, the Guideline International Network Patient 
and Public Involvement Working Group (GIN-Public), and plans for international 
cooperation to develop priorities for research and collaboration on patient and public 
involvement (PPIP) (Boivin, Currie et al. 2010).   Internationally, several studies have 
sought to explore the mechanisms, value and impact of patient and public involvement 
more broadly. NICE’s successful involvement of patients (and/or service users, as 
termed in mental health and as used in this articlei) in guideline development is seen in 
an evaluation of guideline excellence in which 24 schizophrenia guidelines from 18 
countries were compared.   (Gaebel, Weinmann et al. 2005) found that NICE scored 
highest overall and on 5 of 6 domains of quality. Nineteen of the guidelines in this study 
did not include contributions from service users and few had separate ‘patient’ versions 
– components in the NICE guidelines that NICE has produced since the first NICE 
guideline was published in 2002.  Moreover, service user involvement results in 
guidance that is more relevant,	  readable	  and	  understandable	  to	  them,	  as	  reported	  in	  a	  recent	  Cochrane	  review	  (Nilsen,	  Myrhaug	  et	  al.	  2006) 
 Alongside these developments, in mental health over the last decade, attention 
has been drawn to new approaches to improve the wellbeing of people with mental 
health problems, arguably among the most disempowered of patient populations. 
Notably, interest has grown in the ‘recovery’ model, with recovery defined as ‘what 
people experience themselves as they become empowered to manage their lives in a 
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manner that allows them to lead a meaningful life, and a contributing positive sense of 
belonging in their communities’ (NIMHE 2005) This is achieved by helping service users 
determine their own holistically valued outcomes (e.g. vocational, recreational, spiritual, 
interpersonal and educational) as well as those relating to symptom reduction. This 
concerns planning, supporting and co-producing movement towards these goals. A 
related development is the concept of ‘shared decision-making’ that has been gaining 
ground in the USA, which outlines that both the service user and practitioner should 
agree specifically what the ‘problem’ is, how to treat it and what the outcomes of this 
treatment ought to be. Expertise from both the medical and psychiatric evidence-base 
and lived experience contribute to each of these discussions. Incorporating recovery and 
shared decision making principles in the development and implementation of guidelines 
presents a challenge.  
The experience of mental health service users in guideline development 
 	   One	  of	  the	  first	  empirical	  studies	  to	  directly	  examine	  user	  involvement	  in	  guideline	  development	  (van	  Wersch	  and	  Eccles	  2001)	  was	  published	  when	  the	  first	  NICE	  guideline,	  Schizophrenia,	  was	  starting	  development.	  	  It	  painted	  a	  picture	  of	  limited	  service	  user	  participation	  in	  GDGs,	  and	  found	  that	  service	  users	  made relatively few contributions 
to the finished product, the guideline itself, and that they commented on relatively limited 
areas while struggling with technical language and not appearing to value scientific 
evidence in the same way as professional GDG members (those recruited to GDGs by 
virtue of being trained and practicing in health disciplines).  
 At the National Collaborating Centre for Mental Health (NCCMH), as guideline 
development proceeded over the years, there has been considerable interest in 
understanding service user influence on the guideline development process.  In 2007-
2008,  we investigated service users’ own views of their involvement (Harding, Brown et 
al. 2010), interviewing 10 individuals with mental health conditions who had participated 
in completed or ongoing mental health GDGs.   The period of time elapsed since 
involvement in guideline development varied, with some individuals still engaged in 
guideline development at the time of interview whereas other guidelines had been 
completed and published in 2005.  Interview transcripts were analysed using grounded 
theory (Glaser and Strauss 1967).   
The analysis suggests a nuanced view of service user contributions, with four categories 
of influence on guideline development emerging, offering a preliminary basis for further 
theory development. These are:  
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1. Developing expertise from experience:  service users report an awareness of 
ways that relative values of experience and professional knowledge contrast.  
Although both service users and professionals report their personal experience in 
GDG meetings, the experience and knowledge of living with a disorder is 
arguably a broad experience that complements discussion of research evidence 
in meetings.     
2. Overcoming stereotypes to demonstrate value:  service users report playing a 
useful role in guideline development; and doing so requires surmounting barriers 
through translation of unfamiliar technical language, redistribution of power in the 
group, and making debates accessible for all 
3. Unwritten rules influence deliberation – unspoken ‘customs’ concerning 
decision-making and developing recommendations are influential in GDG 
delibarations 
4. Social comparisons affect confidence:  service users may undermine their 
confidence by comparing themselves with others in the group; political and social 
skills are needed to enable individuals to contribute 
 
We suggest that these insights, combined with observations from research in guideline 
development and advances in the recovery movement and in the shared decision-
making clinical model can lead to progress in the following guideline development topics:   
• translation of evidence to recommendations,  
• optimising the acceptability of treatment recommendations to service users, 
•  participants in the treatment decision as different but equal and  
• reconciling different types of knowledge.   
 
Influences on the translation of evidence to recommendations 
 The process of developing guidelines is not a direct conversion of an evidence 
base to recommendations. Socio-political and other influences also impact on the end 
product; this emphasises the importance of understanding interaction in the 
development process.  For example, in a study of value judgements in the development 
of oncology guidelines, (de Kort, Burgers et al. 2009) found that value judgements such 
as what constitutes minimum patient outcomes and preference for tailored treatment, 
influenced the development process, but was not actually reported in the finished 
guidelines, It was unclear whether these value judgements came from patients who were 
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included in both the GDGs and study. This points to the influence of group dynamics and 
to the need to determine how evidence and judgements are wielded in the development 
process. 
 In guidelines, treatment recommendations has been found to not necessarily 
agree with the research evidence.  (Raine, Sanderson et al. 2004) found that little over 
than half of the treatment recommendations agreed with the evidence (51% of 192 
scenarios) in GDGs studied,  surmising that contextual or clinical experience and beliefs 
about research evidence influenced recommendations. Service user judgement is 
arguably developed from lived experience, and as such may be dismissed as 
circumscribed or idiosyncratic. However evidence itself (as in systematic reviews) may 
also be discernibly skewed towards discrete interventions that are easier to examine in 
randomised controlled trials (RCTs) - often not those advocated by service users, which 
may problematise the mechanisms by which they may influence deliberations. 
“Professional” GDG members may value service user experience differently to their own, 
and as such it may not be equally influential. 
 (Pagliari and Grimshaw 2002) argued that the role of professional status has a 
marked effect on the level of contribution to group discussions with increased focus on 
scientific evidence rather than on personal opinion.  The most frequently endorsed was 
‘giving information, clarification or confirmation’, with generic experts / advisors (including 
a health economist, patient advocate, clinical auditor and librarian) making a higher level 
of contribution than general practitioners (GPs) /nurse/professions allied to medicine 
(PAMs) with the patient advocate contribution being the second greatest of their group of 
experts. The influences they postulated on this process were peer support, being in the 
majority, gender and status (compounded by numbers). 
 Our research suggests that power imbalances are indeed perceived within GDGs.   
The category Social comparisons affect confidence relates directly to the differences 
between GDG members that service users detected within, and between disciplines in a 
group.  One participant sums up a view of a power imbalance detected between 
themselves and professional GDG members, and suggests that he expected that this 
would happen: 
 
I think to start off with, um there was as I said a bit of posturing and a bit of power  
positioning, and I think um that can be a lot of problems because as a service user 
there are always these power differentials between the professionals and the 
service users. Participant 4  
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[about another service user representative]…He didn’t have the sort of skills – his 
contribution could only be, you know banging on about the same old points from 
his experience that couldn’t meaningfully be fed into that process. Participant 6 
 
 Here, differences within the service user ‘camp’ suggests an uncomfortably elitist 
approach might be required in developing the recruitment, support and training of 
service user GDG members. Though it is acknowledged that ‘professional’ members of 
GDGs tend to be those leading the relevant field who possess the concomitant personal 
and professional skills, there is no analogous and established training route into being a 
service user professional. It may be inferred that political and social skills are required to 
‘meaningfully’ contribute at this level. Whereas the involvement of service users tends to 
be an inclusive practice, to be successful at this level and to avoid tokenism service user 
representatives may benefit from having relevant prior occupational or personal 
experience that others may not possess.  
 The shared decision-making clinical model observes that joint decision-making 
may be feasible to a lesser extent where the individual is in crisis or lacks capacity, but it 
is still possible.  (Deegan and Drake 2006) suggest that training individual professionals 
in collaborative communication and developing decision support aids can aid in this 
endeavour.  Similarly, we suggest that this approach could form useful components of 
the guideline development process and the resulting guidelines, to enable those with 
less practiced skills to be meaningfully involved in important personal treatment 
decisions. The lack of agreement between service user contributors within the guideline 
development process emphasizes the idiosyncratic nature of personal preferences and 
priorities, both highlighting the complexity of making meaningful treatment decisions and 
the need to focus on the process as well as the outcome of making them.  
 
Improving implementation: Optimising the acceptability of treatment 
recommendations to service users. 
 
 The majority of recommendations made in guidelines relate to the use of 
pharmaceutical interventions. In mental health related guidelines; this is problematised 
by the frequency with which medication is not taken as prescribed.  (Deegan and Drake 
2006) refer to the ‘grey zone’ of uncertain evidence and point to the reality that, despite 
the efficacy of a drug being supported by scientific evidence, its exact benefit to the 
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specific individual for whom it is prescribed cannot be absolutely known in advance.  In 
addition, many issues may influence an individual’s decision to not ‘obey’ the 
prescriber’s directions – the disorder treated may be preferable to the drug; taking 
medication can be stigmatising and serves to remind the individual of their ‘illness’; 
medication may not target the symptoms the individual experiences as distressing, and 
the person may have an alternate explanation than that their difficulties are related to an 
illness, making the idea of taking a medicine nonsensical. Finally, the medication may 
simply be ineffective.  Deegan and Drake (2006:1637) outline that to be successful, 
medication must not interfere with ‘personal medicine’ (‘self-initiated, non-pharmaceutical 
strategies to improve wellness and prevent unwanted outcomes… [Including] activities 
and interventions that give life meaning and purpose’, but it must support and allow the 
pursuit of valued goals (in line with the recovery movement). The esoteric nature of 
some examples of ‘personal medicine’ precludes recommending specific activities (as 
they are, by definition, self determined), but enhancing choice and the process by which 
treatment goals and decisions are made is possible.  
 In GDGs, Harding et al.’s (2010) participants referred to a lack of communication 
about the process of determining treatment recommendations, perhaps reflecting power 
dynamics present in the individual consultation, from which conflicts and power 
imbalances might arise - ‘Unwritten rules influence deliberations’ - a lack of clarity that 
surrounded the guideline development process.  
 
I was a little bit unclear about the process for decision-making because you know I 
don’t think it was ever set out from the beginning how, how decisions were going to 
be reached and whether there was going to be a you know voting process or 
something like that. - Participant 6 
 
The uncertainty about the formal process of making recommendations reportedly left 
some service users wondering how to contribute:  
 
Sometimes it feels that you put a point of view from experience and they come 
back at you and say ‘That’s not what the research shows’ and I’m thinking like well 
that’s not what my contribution is about . . . I’ve wondered about that sometimes, 
well what’s the point of me being here if that’s what you are going to do . . .? 
Participant 2 
  
 The shared decision model (Deegan and Drake 2006)  proposes that when joint 
decision-making replaces the compliance enhancement approach, characterised by 
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paternalistic notions of obedience and the ‘professional knows best’, both parties learn 
about the ‘problem’  through education and valuing different types of expertise and 
determine valued goals and select interventions that do not obstruct but actively support 
movement towards this outcome. The decision-making team includes two experts: one 
who knows the scientific literature and has clinical experience, and one who knows his or 
her preferences and subjective experience’: (p1638).   
 Integrating the two types of expertise through decision support aids such as 
information gathering and sharing tools has been demonstrated to be effective; in an 
RCT with 4783 participants (Deegan 2010),  a software package decision aid was found 
to enhance collaboration on next-step treatment decisions between medication clinic 
clients and their prescribers 82% of the time.  Besides traditional means to support 
patients in guideline development, such as patient inclusion in GDGs, condensed patient 
versions of full guidelines and sharing guidelines via patient organisations, new 
directions include developing decision support aids (for use at the abovementioned 
individual consultation level), grading the level of importance of the intervention 
recommended for patients and highlighting treatment recommendations that are 
particularly sensitive and as such require discussion, as well as outlining appropriate 
techniques for enabling communication about these areas (Boivin, Currie et al. 2010).  
Working with relevant service users to develop these support aids through guideline 
development may benefit the end service user in the consulting room. Shared decision-
making suggests reconciling different types of knowledge but recognises that this is not 
easy for either service user or professional. 
 
Shared decision-making: participants in the treatment decision as different but 
equal 
 Involvement of service users may promote the rights of people often 
disempowered by health services, particularly those receiving treatment for mental 
health problems.   There is increased international support (Boivin, Currie et al. 2010), 
for the view carried out by NICE since its inception that involvement of the recipients of 
treatment and other stakeholders is valuable in its own right and is an essential element 
of the development, implementation and use of treatment guidelines.  Demonstrating 
other benefits, such as increased acceptability of recommendations is likely to build 
support for further improving involvement technologies and the extent to which they are 
embedded in guideline development and implementation processes.  
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 Legare et al. (2009) suggest that not including the preferences and values of 
patients can impede the implementation of treatment recommendations. They refer to 
‘grey’ or scientifically uncertain ‘preference sensitive’ decisions (i.e. where scientific 
evidence does not clearly support one course of action over another in terms of the 
potential harms and benefits) and suggest clinicians and patients need to resolve such 
conflicts.  A further potential source of conflict is between individual and collective goals, 
as observed at an international guideline development workshop from 14 countries on 
service user  involvement  (Boivin, Currie et al. 2010).   Organisations such as 
professional and third sector bodies may be concerned with social accountability 
whereas individuals are more inclined to promote their rights as individuals, to autonomy 
and choice. Reconciling the two requires change by both parties.  
 Service user involvement can occur at different points - the macro, meso and 
micro levels, respectively during the guideline development process; when the guideline 
is implemented and in the individual consultation between patient and practitioner itself 
(Legare, Boivin et al. 2009). . Arguably, the differing priorities of the individual patient 
and the organisation regulating or campaigning for the treatment of their condition may 
variously be more useful and / or relevant one of these levels than another.  
 The success of implementation may well be relevant to the discussion that 
occurs between the patient and practitioner when a treatment is recommended and 
agreed. Many service users ‘expect’ a power imbalance at this stage, and a parallel 
process may be observable within the GDG.   In our previous research, in overcoming 
stereotypes to demonstrate value, service users observed that power imbalances could 
be ameliorated by, for instance, drawing attention to the opaque nature of the terms 
discussed: 
 
We had a very good chair who said ‘explain that’ or would actually say ‘I don’t 
understand what you mean by that’ when I knew jolly well that they (professionals 
on the group) did know and it put them in their place.  
Participant 4  
 
The analysis suggested that in practice, by virtue of being less constrained by 
assumptions about shared understanding implicit in training or practicing as a mental 
health professional, service users may challenge ‘taken-for-granted’ knowledge.  Instead 
of the use of ‘accepted’ terminology becoming a barrier, as has been suggested 
previously, this category refers to ways they used it to make deliberations more 
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accessible. However the epistemology as well as the terminology contained within 
communication is relevant.  As one service user observed:   
 
I have called myself like the language police really.  
Participant 2  
 
Reconciling different types of knowledge 
 
The process of involving service users requires their input in assessing the evidence 
base.  Scientific evidence may be more accessible to those trained and practicing within 
this framework and service users’ personal experience is rarely captured quantitatively in 
large scale studies.  Moreover, RCT evidence included in systematic reviews supporting 
the development of treatment recommendations rarely includes service user led 
research.  (Rose, Wykes et al. 2008) argue that the outcome measures that underpin 
such RCTs cannot be as neutral as their positivist epistemology dictates as long as they 
are derived solely from the perspective of the providers of treatments -clinicians and 
academics.  For example,  participants with mental health problems rate the Global 
Assessment of Functioning (GAF) poorly on the criterion of reflecting outcomes that are 
important to them (Crawford, Robothom et al. submitted).   Moreover, this problem is not 
rectified by Patient Reported Outcome Measures (PROMS), an approach that is 
increasingly used to evaluate health service provision in the UK by gathering patient self 
reports.  Instead, Rose, Wykes et al advocate user generated outcome measures and 
have developed a mechanism for deriving them.  The resulting measures have 
appropriate psychometric properties and are are suitably reliable and valid to warrant 
their inclusion in large-scale studies. 
 In reconciling different types of knowledge, it should first be pointed out that in 
‘Drawing expertise from experience’, as service users – and professionals – do in GDG 
meetings, illustrates the link between value judgements and the utilization of different 
types of evidence.  The value of drawing expertise from experience in reifying concepts 
was demonstrated by the finding that professionals also gave examples from 
experience. For example: 
 
Some of them [professionals] worked very much by talking about people they are 
actually working with at the time … 
Participant 1 
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 This suggests similarities in the ways service users and professionals value their 
experience and in what they consider important ingredients in debate. For instance, 
service users were able to influence decisions on relevant and meaningful outcomes for 
others experiencing difficulties similar to their own, in a way that the evidence base could 
not. 
 
I think the actual experience of living with [disorder] is always so much broader 
than coming down to technical research issues which might be about which 
[medication] worked better, which one do we have the evidence that shows one 
seems to be more effective than another and you start getting that technical 
evidence that comes down to such small points and you think the living experience 
is . . . much bigger.  
Participant 7  
 
At the same time, participants demonstrated an appreciation of the value of professional 
knowledge: 
 
. . . It is kind of knowhow and experience, someone who is really experienced in 
treating the condition can say ‘Well this is what the evidence is but that didn’t work 
so there is no point in trying that again’ or ‘This tends to work quite well with you 
but there’s not a lot of research’ its special, the benefit of experience . . .  
Participant 6  
 
Nonetheless, that the two types of knowledge could be compatible rather than mutually 
exclusive was appreciated, as perhaps might have been assumed by a more 
paternalistic model of treating mental health problems.   
 
They [other group members] I think took the view that what they weren’t going to 
get  was somebody who had a very vertical view on a particular aspect of the 
subject of [disorder] . . . but that I had a broad expertise . . . and it complemented 
theirs.   
Participant 5 
 
The notion of collective knowledge or experiential expertise (where experiences of living 
with a particular disorder and interventions provided ‘‘are converted, consciously or 
unconsciously, into a personal insight’’ (Caron-Flinterman, Broerse et al. 2005) p. 2576 
responds to the criticism often leveled at personal experience and qualitative data, that it 
is idiosyncratic. Instead, it is possible that knowledge transmitted between service users 
informs individuals’ judgement.  
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In my case I have had lots of personal experience but also lots of personal contact 
with lots of other service user reps . . . so I am not just talking from my own 
personal experience but a whole marshalling of anecdotal evidence . . . 
 Participant 3  
 
The use of supervision and other communications between mental health professionals 
suggests this is not limited to the recipients of treatment.  
 
 
Conclusion 
 
Shared decision-making seeks to resolve power imbalances and moves instead towards 
a position appreciating heterogeneity along with the merits of different types of 
knowledge in determining and implementing treatment goals and interventions.  The 
involvement of patients and the public, but specifically users of mental health services, in 
determining treatment recommendations and the way they are made may then 
strengthen the integrity of s and improve their implementation whilst advancing recovery 
and shared decision-making models.  Whilst it may be argued that guidelines should 
restrict themselves to listing optimal treatments for specific disorders, the human factors 
involved in deciding what these might be make the process of deliberation as significant 
as the outcome, within both the guideline development and the individual clinician-
patient consultation.  Involving patients and service users in developing treatment 
recommendations may itself improve the relevance and acceptability (to service users 
and patients) of the resulting guideline. By also considering the implementation of 
guidance at the point it is used, by developing decision aids and considering both 
parties’ involvement in the process of determining treatment goals and interventions is 
consistent with recovery values currently permeating mental health services 
internationally. 
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i Also frequently used is patient and public involvement (PPIP) 
